Variant report

Variant	nsv900791
Chromosome Location	chr13:88623302-88771495
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:1)
LncRNA
region (count:11)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr13:88332679..88333285-chr13:88652174..88653031,2	MCF-7	breast:

(count:11 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SLITRK6-17	chr13:88668490-88668550	NONHSAT034605
2	lnc-SLITRK6-17	chr13:88665102-88665582	NONHSAT034605
3	lnc-SLITRK6-17	chr13:88670789-88670814	NONHSAT034606
4	lnc-SLITRK5-15	chr13:88729922-88730495	NONHSAT034607
5	lnc-SLITRK6-17	chr13:88665151-88665582	NONHSAT034606
6	lnc-SLITRK6-17	chr13:88687074-88687145	NONHSAT034605
7	lnc-SLITRK6-17	chr13:88669827-88669964	NONHSAT034605
8	lnc-SLITRK6-17	chr13:88670789-88670814	NONHSAT034605
9	lnc-SLITRK5-15	chr13:88723458-88723617	NONHSAT034607
10	lnc-SLITRK6-17	chr13:88666229-88666396	NONHSAT034606
11	lnc-SLITRK6-17	chr13:88668490-88668550	NONHSAT034606

No data

Extended variants
information (count: 2078 )
Associated
traits (count: 88 )

Variant overlapped rSNPs/rCNVs (count:2078 , 50 per page) page: 1 2 3 4 5 6 7 ... 42

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs539824196	chr13:88626800-88626801	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs180727947	chr13:88626847-88626848	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs548375051	chr13:88626882-88626883	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs566673769	chr13:88626903-88626904	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs150540199	chr13:88626918-88626919	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs558817562	chr13:88626965-88626966	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs72641981	chr13:88627047-88627048	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs539007952	chr13:88627068-88627069	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs556964556	chr13:88627072-88627073	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs566599907	chr13:88627122-88627123	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs575307792	chr13:88627150-88627151	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs556632029	chr13:88627156-88627157	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs533949934	chr13:88627157-88627158	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs74912935	chr13:88627184-88627185	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs573389710	chr13:88627197-88627198	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs540514747	chr13:88627258-88627259	Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs565559668	chr13:88627309-88627310	Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs576522413	chr13:88627320-88627321	Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs532730481	chr13:88627363-88627364	Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs570443718	chr13:88627456-88627457	Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs186458220	chr13:88627469-88627470	Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs190837035	chr13:88627564-88627565	Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs529780994	chr13:88627567-88627568	Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs548316309	chr13:88627602-88627603	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs566500887	chr13:88627626-88627627	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs537736713	chr13:88627675-88627676	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs183369588	chr13:88627712-88627713	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs552122052	chr13:88627753-88627754	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs570703468	chr13:88627758-88627759	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs187663502	chr13:88627795-88627796	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs556901115	chr13:88627796-88627797	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs562490006	chr13:88633617-88633618	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs574440117	chr13:88633632-88633633	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs541571152	chr13:88633636-88633637	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs139688172	chr13:88633745-88633746	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs527483917	chr13:88633776-88633777	Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs551986190	chr13:88633810-88633811	Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs186490497	chr13:88633816-88633817	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs78552896	chr13:88633820-88633821	Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs74104001	chr13:88633926-88633927	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs550524259	chr13:88633927-88633928	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs7490922	chr13:88634017-88634018	Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs7992325	chr13:88634024-88634025	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs530159116	chr13:88634051-88634052	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs548388184	chr13:88634054-88634055	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs550317949	chr13:88634085-88634086	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs566997008	chr13:88634091-88634092	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs566400931	chr13:88634097-88634098	Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs547658827	chr13:88634099-88634100	Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs534378232	chr13:88634116-88634117	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:88)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
HIV/AIDS	22032296	CNVD
Prostate cancer	16705090	CNVD
High-proliferative meningiomas	17937814	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Chordoma	21602918	CNVD
Bladder cancer	21949216	CNVD
Acute myeloid leukemia	16864856	CNVD
Burkitt''s lymphoma	18698080	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	21518781	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Ovarian cancer	20844748	CNVD
Colorectal cancer	19359472	CNVD
Intracranial aneurysm	19064780	CNVD
Breast cancer	19287154	CNVD
Acute myeloid leukemia	18379011	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Multiple myeloma	17077331	CNVD
Ependymoma	16718352	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Ovarian cancer	22174824	CNVD
Myoepithelioma	18604193	CNVD
Breast cancer	17133270	CNVD
Prostate cancer	18632612	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Developmental delay	21147756	CNVD
Melanoma	18172304	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Basal cell lymphoma	17053054	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Metanephric adenoma	20802469	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Gastric cancer	17908304	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Liposarcoma	21253554	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
abnormal development	18461090	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Esophageal cancer	21851588	CNVD
Prostate cancer	21965145	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Cancer	21220470	CNVD
Cancer	21183584	CNVD
Omodysplasia	19481194	CNVD
Breast cancer	22032731	CNVD
Mantle cell lymphoma	19690137	CNVD
Rhabdomyosarcoma	17210683	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Gastric adenocarcinoma	19115996	CNVD
Mental retardation	17847001	CNVD
Medulloblastoma	19270706	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-small cell lung cancer	16651412	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:100 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:88626800-88627000	Enhancers	Muscle Satellite Cultured Cells	--
2	chr13:88626800-88627600	Enhancers	HSMM	muscle
3	chr13:88627000-88627400	Enhancers	HMEC	breast
4	chr13:88627000-88627800	Flanking Active TSS	Muscle Satellite Cultured Cells	--
5	chr13:88627000-88627800	Enhancers	NHEK	skin
6	chr13:88627200-88627600	Active TSS	HSMMtube	muscle
7	chr13:88633600-88634000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
8	chr13:88633600-88634200	Enhancers	Muscle Satellite Cultured Cells	--
9	chr13:88633800-88634600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
10	chr13:88634400-88635000	Enhancers	Fetal Brain Male	brain
11	chr13:88650400-88650800	ZNF genes & repeats	H1 Derived Mesenchymal Stem Cells	ES cell derived
12	chr13:88650400-88650800	ZNF genes & repeats	iPS DF 6.9 Cell Line	embryonic stem cell
13	chr13:88650400-88651200	ZNF genes & repeats	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
14	chr13:88650800-88652200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
15	chr13:88651200-88651400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
16	chr13:88651200-88651400	Weak transcription	HSMM	muscle
17	chr13:88651200-88652800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
18	chr13:88651200-88653000	Enhancers	NH-A	brain
19	chr13:88651400-88652800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
20	chr13:88651400-88652800	Enhancers	HSMMtube	muscle
21	chr13:88651400-88653000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
22	chr13:88651400-88653000	Enhancers	Muscle Satellite Cultured Cells	--
23	chr13:88651400-88653400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
24	chr13:88651400-88653600	Enhancers	HSMM	muscle
25	chr13:88651400-88653800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
26	chr13:88651600-88652400	Enhancers	HMEC	breast
27	chr13:88651600-88652600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
28	chr13:88651600-88652600	Enhancers	NHEK	skin
29	chr13:88652000-88652400	Enhancers	Placenta Amnion	Placenta Amnion
30	chr13:88652000-88652800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
31	chr13:88652200-88653400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
32	chr13:88652200-88653600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
33	chr13:88652400-88653000	Enhancers	NHLF	lung
34	chr13:88652800-88653000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
35	chr13:88652800-88657200	Weak transcription	HSMMtube	muscle
36	chr13:88653400-88670400	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
37	chr13:88653600-88657200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
38	chr13:88657200-88658000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
39	chr13:88657200-88658400	Enhancers	HSMMtube	muscle
40	chr13:88658000-88658400	ZNF genes & repeats	Spleen	Spleen
41	chr13:88666600-88667400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
42	chr13:88666800-88667600	Enhancers	Primary monocytes fromperipheralblood	blood
43	chr13:88673000-88675000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
44	chr13:88673200-88673800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
45	chr13:88674600-88674800	Enhancers	Monocytes-CD14+_RO01746	blood
46	chr13:88674600-88676000	Enhancers	Primary monocytes fromperipheralblood	blood
47	chr13:88674800-88675200	Enhancers	Muscle Satellite Cultured Cells	--
48	chr13:88674800-88675200	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
49	chr13:88674800-88676000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
50	chr13:88675200-88675800	Enhancers	Monocytes-CD14+_RO01746	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links